Game-based education for children with type 1 diabetes
Official title: The Effect of Education Provided to Children With Type 1 Diabetes Using Gamification Methods on Health Literacy and Quality of Life: A Randomized Controlled Trial
Run by KTO Karatay University · NCT07409701 · Data updated 2026-11-12
We will test if a game-based education program helps children aged 8–12 with type 1 diabetes improve their health knowledge and quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years to 12 Years |
| Sex | All |
| Enrollment | 52 (estimated) |
| Sponsor | KTO Karatay University Academic / other |
| Locations | 1 site (Ankara, Yenimahalle) |
| Status | Recruiting |
| Started | January 25, 2026 |
| Main results expected | April 30, 2026 |
| Study ends | April 30, 2027 |
| Registry record updated | August 13, 2026 |
| Trial ID | NCT07409701 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 8–12 with a diagnosis of type 1 diabetes for at least one year who can read and write and do not have sensory or cognitive impairments are ideal candidates.
✕Probably not a fit
Children with speech, hearing, or visual impairments, other chronic comorbidities, cognitive impairment, or those outside the 8–12 age range or newly diagnosed may be unlikely to benefit from this specific intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, parallel-group (1:1) controlled trial enrolling 52 children with type 1 diabetes at Ankara Etlik City Hospital between January and April 2026. Eligible participants are aged 8–12, diagnosed with T1DM for at least one year, able to read and write, and without major sensory or cognitive impairments. The intervention group will receive gamified diabetes education while the control group receives usual care, with data collected by individual interviews using a demographic form, a diabetes-specific health literacy scale, and a pediatric diabetes quality-of-life scale. Outcomes will be compared using a pre-test/post-test design to see if gamification changes health literacy and quality-of-life scores.
Why it matters
Potential benefit: If successful, the gamified education could improve diabetes-related health literacy and quality of life in children, potentially supporting better self-care and fewer acute problems.
How similar studies have gone: Prior small studies of gamified education in pediatric chronic conditions, including some work in diabetes, have shown improved engagement and short-term knowledge gains, but durable quality-of-life or clinical benefits remain limited and inconsistently demonstrated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with type 1 diabetes * Aged between 8 and 12 years * Diagnosed with type 1 diabetes for at least 1 year and having received standard diabetes education * Able to read and write Exclusion Criteria: * Presence of speech, hearing, or visual impairments * Presence of any other comorbid chronic disease * Presence of cognitive impairment
Where it's running
-
Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Gülfidan Başer
- Email: gulfidan.baser@karatay.edu.tr
- Phone: 4441251-7550
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
VV-14300: a gene therapy approach for adults with type 1 diabetes not well controlled on an automated insulin system
This trial tests VV-14300 in adults with type 1 diabetes who aren’t reaching their blood sugar goals despite using an automated insulin delivery system.
-
New gene therapies VV-14299 and VV-14300 for adults with Type 1 Diabetes failing automated insulin delivery
This study tests VV-14299 and VV-14300, or VV-14300 alone, in adults with long-standing Type 1 Diabetes whose blood sugar remains poorly controlled despite using an automated insulin delivery system.
-
Oral verapamil in newly diagnosed children and teens with type 1 diabetes
This study tests whether taking verapamil by mouth can help preserve pancreatic beta cells and reduce insulin needs in kids and teens with recently diagnosed type 1 diabetes.
-
Preventing device-related skin rashes in kids with type 1 diabetes using hydrocolloid vs silicone patches
This study tests whether silicone-based or hydrocolloid patches help prevent recurring skin irritation from insulin pumps or CGMs in children and teens with type 1 diabetes.
-
AI-assisted remote insulin pump optimization for people with type 1 diabetes
This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.
-
Near-sensor insulin delivery with CGM in people with type 1 diabetes
A small early-feasibility study tests a dual-port insulin patch pump that includes a CGM sensor to see if delivering insulin near the sensor affects glucose readings and whether an automated control algorithm can manage glucose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.